Brookline, MA, United States of America

Yves Borel

This inventor holds 1 USPTO granted patent. Top assignee: Children's Medical Center Corporation. Active years: 1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yves Borel. Retrieved from https://idiyas.com/inventor/yves-borel-llrtto9m

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 95(Granted Patents)


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yves Borel: Innovator in Oligonucleotide Conjugates

Introduction

Yves Borel is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of oligonucleotide conjugates. His work has implications for various medical applications, showcasing the intersection of innovation and healthcare.

Latest Patents

Yves Borel holds a patent for "Oligonucleotide conjugates," which describes a conjugate composed of an oligonucleotide covalently bonded to a carrier. This invention represents a step forward in the utilization of oligonucleotides in therapeutic contexts.

Career Highlights

Borel is affiliated with the Children's Medical Center Corporation, where he continues to advance his research and development efforts. His work at this institution underscores his commitment to improving medical outcomes through innovative solutions.

Collaborations

Yves Borel has collaborated with notable colleagues, including B David Stollar and Helina Borel. These partnerships reflect a collaborative spirit in the pursuit of scientific advancement.

Conclusion

Yves Borel's contributions to the field of biotechnology, particularly through his patent on oligonucleotide conjugates, highlight his role as an innovator dedicated to enhancing medical science. His work continues to inspire advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…